Literature DB >> 33956887

Correction: Correction: Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study.

.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0250185.].

Entities:  

Year:  2021        PMID: 33956887      PMCID: PMC8101919          DOI: 10.1371/journal.pone.0251539

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


There are errors in the Correction published on April 8, 2021. The corrected figures are incorrect. The correct figures are: Prevalence rates of anti-HAV IgG (A), HBsAg (B), anti-HBc IgG (C), anti-HBs ≥10 mUI/ml (D) and anti-HEV IgG (E) by age groups in different regions of Peru. Prevalence rates of anti-HAV IgG (A), HBsAg (B), anti-HBc IgG (C), anti-HBs ≥10 mUI/ml (D) and anti-HEV IgG (E) by age groups in urban and rural areas of Peru. Prevalence of HBsAg and hepatitis Delta before (A) [19] and after the implementation of the hepatitis B vaccination program in Peru (B). The publisher apologizes for the errors.
  2 in total

1.  Correction: Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study.

Authors: 
Journal:  PLoS One       Date:  2021-04-08       Impact factor: 3.240

2.  Seroepidemiology of hepatitis A, B, C, D and E virus infections in the general population of Peru: A cross-sectional study.

Authors:  Cesar Cabezas; Omar Trujillo; Ángel Gonzales-Vivanco; Carlos Manuel Benites Villafane; Johanna Balbuena; Alfredo Oswaldo Borda-Olivas; Magna Aurora Suarez-Jara; Flor de María Peceros; Max Carlos Ramírez-Soto
Journal:  PLoS One       Date:  2020-06-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.